Skip to content
Recall Observatory FDA recall evidence

Drug product

chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01

D-0159-2025

December 11, 2024

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 95936
Status
Ongoing
Classification
Class II
Quantity
3,888
Official record key
drug-enforcement:D-0159-2025

Official wording

Reason: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

Code information: Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025

Distribution pattern: USA Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso-Desmethyl Chlorpromazine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations